Published in Hum Mol Genet on June 29, 2005
Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. Cancer Cell (2011) 11.44
HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations. J Clin Invest (2013) 3.55
Cell-permeating alpha-ketoglutarate derivatives alleviate pseudohypoxia in succinate dehydrogenase-deficient cells. Mol Cell Biol (2007) 3.33
NRF2 and cancer: the good, the bad and the importance of context. Nat Rev Cancer (2012) 3.04
Renal cyst formation in Fh1-deficient mice is independent of the Hif/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling. Cancer Cell (2011) 3.00
Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. Genes Dev (2012) 2.70
Influence of metabolism on epigenetics and disease. Cell (2013) 2.64
Loss of the SdhB, but Not the SdhA, subunit of complex II triggers reactive oxygen species-dependent hypoxia-inducible factor activation and tumorigenesis. Mol Cell Biol (2007) 2.45
Fumarate hydratase deficiency in renal cancer induces glycolytic addiction and hypoxia-inducible transcription factor 1alpha stabilization by glucose-dependent generation of reactive oxygen species. Mol Cell Biol (2009) 2.27
The glycolytic shift in fumarate-hydratase-deficient kidney cancer lowers AMPK levels, increases anabolic propensities and lowers cellular iron levels. Cancer Cell (2011) 2.12
UOK 262 cell line, fumarate hydratase deficient (FH-/FH-) hereditary leiomyomatosis renal cell carcinoma: in vitro and in vivo model of an aberrant energy metabolic pathway in human cancer. Cancer Genet Cytogenet (2010) 2.06
Inborn and acquired metabolic defects in cancer. J Mol Med (Berl) (2011) 2.06
Mitochondrial reactive oxygen species production in excitable cells: modulators of mitochondrial and cell function. Antioxid Redox Signal (2009) 1.89
Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel? Nat Rev Cancer (2014) 1.89
Cancer and altered metabolism: potential importance of hypoxia-inducible factor and 2-oxoglutarate-dependent dioxygenases. Cold Spring Harb Symp Quant Biol (2011) 1.81
Oncometabolites: linking altered metabolism with cancer. J Clin Invest (2013) 1.78
Metabolism of kidney cancer: from the lab to clinical practice. Eur Urol (2012) 1.75
Succinate dehydrogenase-deficient GISTs: a clinicopathologic, immunohistochemical, and molecular genetic study of 66 gastric GISTs with predilection to young age. Am J Surg Pathol (2011) 1.73
Hypoxia-inducible factor-1alpha regulates beta cell function in mouse and human islets. J Clin Invest (2010) 1.70
Signal transduction by mitochondrial oxidants. J Biol Chem (2011) 1.65
Hypoxia-inducible factor linked to differential kidney cancer risk seen with type 2A and type 2B VHL mutations. Mol Cell Biol (2007) 1.62
Tumor biology and prognostic factors in renal cell carcinoma. Oncologist (2011) 1.62
Fumarase: a mitochondrial metabolic enzyme and a cytosolic/nuclear component of the DNA damage response. PLoS Biol (2010) 1.61
State of the science: an update on renal cell carcinoma. Mol Cancer Res (2012) 1.58
Structural basis of fumarate hydratase deficiency. J Inherit Metab Dis (2011) 1.58
Succinate dehydrogenase - Assembly, regulation and role in human disease. Mitochondrion (2010) 1.56
Regulation of human metabolism by hypoxia-inducible factor. Proc Natl Acad Sci U S A (2010) 1.56
The proto-oncometabolite fumarate binds glutathione to amplify ROS-dependent signaling. Mol Cell (2013) 1.54
Oxygen consumption can regulate the growth of tumors, a new perspective on the Warburg effect. PLoS One (2009) 1.52
Revisiting the TCA cycle: signaling to tumor formation. Trends Mol Med (2011) 1.51
Multiple hits for the association of uterine fibroids on human chromosome 1q43. PLoS One (2013) 1.50
Protein lysine acylation and cysteine succination by intermediates of energy metabolism. ACS Chem Biol (2012) 1.49
SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma-paraganglioma syndromes. J Intern Med (2009) 1.47
Disruption of tubular Flcn expression as a mouse model for renal tumor induction. Kidney Int (2015) 1.46
Hypoxia signaling pathways in cancer metabolism: the importance of co-selecting interconnected physiological pathways. Cancer Metab (2014) 1.45
The FH mutation database: an online database of fumarate hydratase mutations involved in the MCUL (HLRCC) tumor syndrome and congenital fumarase deficiency. BMC Med Genet (2008) 1.38
Oxygen sensing and hypoxia signalling pathways in animals: the implications of physiology for cancer. J Physiol (2013) 1.35
Molecular pathways: Fumarate hydratase-deficient kidney cancer--targeting the Warburg effect in cancer. Clin Cancer Res (2013) 1.34
Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background. Cancer Genet (2012) 1.34
Redox regulation of mitochondrial function. Antioxid Redox Signal (2012) 1.34
Dysregulation of hypoxia pathways in fumarate hydratase-deficient cells is independent of defective mitochondrial metabolism. Hum Mol Genet (2010) 1.33
New insights into the biology of renal cell carcinoma. Hematol Oncol Clin North Am (2011) 1.31
Hereditary leiomyomatosis and renal cell cancer: update on clinical and molecular characteristics. Fam Cancer (2011) 1.30
Oxidative stress and transcriptional regulation in Alzheimer disease. Alzheimer Dis Assoc Disord (2007) 1.29
HIF and fumarate hydratase in renal cancer. Br J Cancer (2007) 1.27
Nitrogen anabolism underlies the importance of glutaminolysis in proliferating cells. Cell Cycle (2010) 1.27
L-2-Hydroxyglutarate: an epigenetic modifier and putative oncometabolite in renal cancer. Cancer Discov (2014) 1.26
Inactivation of the FLCN tumor suppressor gene induces TFE3 transcriptional activity by increasing its nuclear localization. PLoS One (2010) 1.23
Hypoxia inducible factor prolyl 4-hydroxylase enzymes: center stage in the battle against hypoxia, metabolic compromise and oxidative stress. Neurochem Res (2007) 1.22
Reactive oxygen species regulate hypoxia-inducible factor 1alpha differentially in cancer and ischemia. Mol Cell Biol (2008) 1.21
Somatic pairing of chromosome 19 in renal oncocytoma is associated with deregulated EGLN2-mediated [corrected] oxygen-sensing response. PLoS Genet (2008) 1.20
TET proteins and 5-methylcytosine oxidation in hematological cancers. Immunol Rev (2015) 1.18
Alterations of metabolic genes and metabolites in cancer. Semin Cell Dev Biol (2012) 1.18
JmjC enzyme KDM2A is a regulator of rRNA transcription in response to starvation. EMBO J (2010) 1.17
Central carbon metabolism in the progression of mammary carcinoma. Breast Cancer Res Treat (2007) 1.16
Inter-connection between mitochondria and HIFs. J Cell Mol Med (2010) 1.14
Fatty acid labeling from glutamine in hypoxia can be explained by isotope exchange without net reductive isocitrate dehydrogenase (IDH) flux. J Biol Chem (2013) 1.13
Hyperpolarized 13C-pyruvate magnetic resonance reveals rapid lactate export in metastatic renal cell carcinomas. Cancer Res (2012) 1.13
Metastatic paraganglioma. Semin Oncol (2010) 1.12
Metabolic defects provide a spark for the epigenetic switch in cancer. Free Radic Biol Med (2009) 1.10
Relevance of mitochondrial genetics and metabolism in cancer development. Cold Spring Harb Perspect Biol (2013) 1.08
Hypoxia-inducible factor prolyl-4-hydroxylase PHD2 protein abundance depends on integral membrane anchoring of FKBP38. J Biol Chem (2009) 1.08
The emerging role of fumarate as an oncometabolite. Front Oncol (2012) 1.08
Current approaches and recent developments in the management of head and neck paragangliomas. Endocr Rev (2014) 1.07
Fumarate hydratase enzyme activity in lymphoblastoid cells and fibroblasts of individuals in families with hereditary leiomyomatosis and renal cell cancer. J Med Genet (2006) 1.07
Exploiting mitochondrial dysfunction for effective elimination of imatinib-resistant leukemic cells. PLoS One (2011) 1.05
Tumor cell metabolism: an integral view. Cancer Biol Ther (2011) 1.04
Fumarate induces redox-dependent senescence by modifying glutathione metabolism. Nat Commun (2015) 1.04
Targeted therapeutic strategies for the management of renal cell carcinoma. Curr Opin Oncol (2012) 1.00
SDH-related pheochromocytoma and paraganglioma. Best Pract Res Clin Endocrinol Metab (2010) 1.00
Succinate-to-fumarate ratio as a new metabolic marker to detect the presence of SDHB/D-related paraganglioma: initial experimental and ex vivo findings. Endocrinology (2013) 1.00
Transcriptional Regulation of SDHa flavoprotein by nuclear respiratory factor-1 prevents pseudo-hypoxia in aerobic cardiac cells. J Biol Chem (2008) 1.00
Reversed argininosuccinate lyase activity in fumarate hydratase-deficient cancer cells. Cancer Metab (2013) 1.00
Physiological consequences of complex II inhibition for aging, disease, and the mKATP channel. Biochim Biophys Acta (2013) 0.99
Hereditary leiomyomatosis and renal cell carcinoma. Int J Nephrol Renovasc Dis (2014) 0.99
A role for cytosolic fumarate hydratase in urea cycle metabolism and renal neoplasia. Cell Rep (2013) 0.99
Fumarate and Succinate Regulate Expression of Hypoxia-inducible Genes via TET Enzymes. J Biol Chem (2015) 0.99
Hypoxia-inducible factor signaling in pheochromocytoma: turning the rudder in the right direction. J Natl Cancer Inst (2013) 0.98
Elevated plasma succinate in PTEN, SDHB, and SDHD mutation-positive individuals. Genet Med (2012) 0.98
Exploring a glycolytic inhibitor for the treatment of an FH-deficient type-2 papillary RCC. Nat Rev Urol (2011) 0.98
Krebs cycle metabolite profiling for identification and stratification of pheochromocytomas/paragangliomas due to succinate dehydrogenase deficiency. J Clin Endocrinol Metab (2014) 0.97
Three autocrine feedback loops determine HIF1 alpha expression in chronic hypoxia. Biochim Biophys Acta (2007) 0.97
Mitochondrial bioenergetic adaptations of breast cancer cells to aglycemia and hypoxia. J Bioenerg Biomembr (2010) 0.96
Genetic basis for kidney cancer: opportunity for disease-specific approaches to therapy. Expert Opin Biol Ther (2008) 0.96
A new specific succinate-glutamate metabolomic hallmark in SDHx-related paragangliomas. PLoS One (2013) 0.96
Loss of the respiratory enzyme citrate synthase directly links the Warburg effect to tumor malignancy. Sci Rep (2012) 0.96
Metabolic alterations in cancer cells and therapeutic implications. Chin J Cancer (2011) 0.96
Mitochondrial dysfunction impairs tumor suppressor p53 expression/function. J Biol Chem (2011) 0.95
Hypoxia-dependent sequestration of an oxygen sensor by a widespread structural motif can shape the hypoxic response--a predictive kinetic model. BMC Syst Biol (2010) 0.94
The role of angiogenic factors in fibroid pathogenesis: potential implications for future therapy. Hum Reprod Update (2013) 0.93
Metabolomics Reveals a Key Role for Fumarate in Mediating the Effects of NADPH Oxidase 4 in Diabetic Kidney Disease. J Am Soc Nephrol (2015) 0.93
Assessment of hypoxia inducible factor levels in cancer cell lines upon hypoxic induction using a novel reporter construct. PLoS One (2011) 0.93
Inactivation of SDH and FH cause loss of 5hmC and increased H3K9me3 in paraganglioma/pheochromocytoma and smooth muscle tumors. Oncotarget (2015) 0.93
MUC1: a novel metabolic master regulator. Biochim Biophys Acta (2014) 0.92
Metabolic mechanisms of epigenetic regulation. ACS Chem Biol (2013) 0.92
Loss of succinate dehydrogenase activity results in dependency on pyruvate carboxylation for cellular anabolism. Nat Commun (2015) 0.92
Insights into the pathogenesis and treatment of cancer from inborn errors of metabolism. Am J Hum Genet (2011) 0.91
Hypoxia inducible factor-1 mediates effects of insulin on pancreatic cancer cells and disturbs host energy homeostasis. Am J Pathol (2007) 0.91
Chicken or the egg: Warburg effect and mitochondrial dysfunction. F1000Prime Rep (2015) 0.91
Mapping of succinate dehydrogenase losses in 2258 epithelial neoplasms. Appl Immunohistochem Mol Morphol (2014) 0.90
Cyclin: a protein specified by maternal mRNA in sea urchin eggs that is destroyed at each cleavage division. Cell (1983) 9.90
A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell (1994) 8.52
Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis in mice. Nat Genet (1998) 7.89
Preparation and use of nuclease-treated rabbit reticulocyte lysates for the translation of eukaryotic messenger RNA. Methods Enzymol (1983) 7.38
Phosphorylation of initiation factor elF-2 and the control of reticulocyte protein synthesis. Cell (1977) 6.22
Human DNA repair genes. Science (2001) 6.11
Value of assessment of pretest probability of deep-vein thrombosis in clinical management. Lancet (1998) 6.04
Prevalence of antibody to human T-lymphotropic virus type III in AIDS and AIDS-risk patients in Britain. Lancet (1984) 5.20
Cut2 proteolysis required for sister-chromatid seperation in fission yeast. Nature (1996) 4.86
Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum Mol Genet (1998) 4.72
Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. JAMA (1999) 4.71
Cyclin is a component of maturation-promoting factor from Xenopus. Cell (1990) 4.70
Translation of cyclin mRNA is necessary for extracts of activated xenopus eggs to enter mitosis. Cell (1989) 4.56
Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia. Nat Genet (1997) 4.26
The A- and B-type cyclin associated cdc2 kinases in Xenopus turn on and off at different times in the cell cycle. EMBO J (1990) 4.25
Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. Lancet (1999) 4.20
Anaphase-promoting complex/cyclosome-dependent proteolysis of human cyclin A starts at the beginning of mitosis and is not subject to the spindle assembly checkpoint. J Cell Biol (2001) 3.86
Messenger RNA for the coat protein of tobacco mosaic virus. Nature (1976) 3.85
Control of globin synthesis: the role of heme. J Mol Biol (1972) 3.47
Management of dizziness in primary care. J Am Board Fam Pract (1994) 3.33
Immunologic investigations of mucoid strains of Pseudomonas aeruginosa: comparison of susceptibility to opsonic antibody in mucoid and nonmucoid strains. J Infect Dis (1980) 3.29
Hepatocytes from non-hepatic adult stem cells. Nature (2000) 3.27
PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome. Hum Mol Genet (1999) 3.22
Peutz-Jeghers syndrome: a systematic review and recommendations for management. Gut (2010) 3.22
Cyclin A and the retinoblastoma gene product complex with a common transcription factor. Nature (1991) 3.15
The proteolysis of mitotic cyclins in mammalian cells persists from the end of mitosis until the onset of S phase. EMBO J (1996) 3.12
Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits. Nat Genet (2001) 3.10
Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nat Genet (1995) 3.09
Bone marrow contributes to renal parenchymal turnover and regeneration. J Pathol (2001) 3.04
The cdc2-related protein p40MO15 is the catalytic subunit of a protein kinase that can activate p33cdk2 and p34cdc2. EMBO J (1993) 3.03
Double-stranded poliovirus RNA inhibits initiation of protein synthesis by reticulocyte lysates. Proc Natl Acad Sci U S A (1971) 2.99
The use of single-stranded DNA and RNase H to promote quantitative 'hybrid arrest of translation' of mRNA/DNA hybrids in reticulocyte lysate cell-free translations. Nucleic Acids Res (1986) 2.97
The 3'-untranslated regions of c-mos and cyclin mRNAs stimulate translation by regulating cytoplasmic polyadenylation. Genes Dev (1994) 2.95
Triggering of cyclin degradation in interphase extracts of amphibian eggs by cdc2 kinase. Nature (1990) 2.89
The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations. Br J Cancer (2005) 2.85
The characteristics of inhibition of protein synthesis by double-stranded ribonucleic acid in reticulocyte lysates. J Biol Chem (1975) 2.84
Initiation of protein synthesis: evidence for messenger RNA-independent binding of methionyl-transfer RNA to the 40 S ribosomal subunit. J Mol Biol (1973) 2.80
Cyclin is a component of the sea urchin egg M-phase specific histone H1 kinase. EMBO J (1989) 2.75
TERC polymorphisms are associated both with susceptibility to colorectal cancer and with longer telomeres. Gut (2011) 2.75
Are cancer cells acidic? Br J Cancer (1991) 2.72
Molecular cloning and characterization of the mRNA for cyclin from sea urchin eggs. EMBO J (1987) 2.71
A brain-specific activator of cyclin-dependent kinase 5. Nature (1994) 2.71
Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q. Qual Life Res (2002) 2.66
Extended lamivudine retreatment for chronic hepatitis B: maintenance of viral suppression after discontinuation of therapy. Hepatology (1999) 2.64
The localisation of excretion in the uriniferous tubule: Part II. J Physiol (1924) 2.60
Dilated cardiomyopathy and atrioventricular conduction blocks induced by heart-specific inactivation of mitochondrial DNA gene expression. Nat Genet (1999) 2.57
Selective translation of mRNA controls the pattern of protein synthesis during early development of the surf clam, Spisula solidissima. Cell (1980) 2.49
Pearson's marrow-pancreas syndrome. A multisystem mitochondrial disorder in infancy. J Clin Invest (1990) 2.46
Causes and consequences of tumour acidity and implications for treatment. Mol Med Today (2000) 2.44
Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med (2003) 2.44
Control of protein synthesis in reticulocyte lysates by haemin. Nat New Biol (1973) 2.39
Cyclin synthesis, modification and destruction during meiotic maturation of the starfish oocyte. Dev Biol (1987) 2.35
Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues. J Pathol (1990) 2.29
The crystal structure of cyclin A. Structure (1995) 2.28
The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway. Am J Hum Genet (2001) 2.28
Ultrasonographic screening before hospital discharge for deep venous thrombosis after arthroplasty: the post-arthroplasty screening study. A randomized, controlled trial. Ann Intern Med (1997) 2.28
The APC variants I1307K and E1317Q are associated with colorectal tumors, but not always with a family history. Proc Natl Acad Sci U S A (1998) 2.27
Alopecia universalis associated with a mutation in the human hairless gene. Science (1998) 2.23
Polyclonal origin of colonic adenomas in an XO/XY patient with FAP. Science (1996) 2.22
The role of proteolysis in cell cycle progression in Schizosaccharomyces pombe. EMBO J (1996) 2.13
Identification of a metaplastic cell lineage associated with human gastric adenocarcinoma. Lab Invest (1999) 2.10
The c-mos proto-oncogene protein kinase turns on and maintains the activity of MAP kinase, but not MPF, in cell-free extracts of Xenopus oocytes and eggs. EMBO J (1993) 2.10
Rheumatoid arthritis, corticosteroid therapy and hip fracture. Ann Rheum Dis (1995) 2.10
A novel gene (PLU-1) containing highly conserved putative DNA/chromatin binding motifs is specifically up-regulated in breast cancer. J Biol Chem (1999) 2.09
High levels of type VII collagen expression in recessive dystrophic epidermolysis bullosa cutaneous squamous cell carcinoma keratinocytes increases PI3K and MAPK signalling, cell migration and invasion. Br J Dermatol (2014) 2.09
On the translational control of suicide in red cell development. Trends Biochem Sci (1989) 2.09
Size and physical map of the chromosome of Haemophilus influenzae. J Bacteriol (1989) 2.07
Control of mitochondrial membrane permeabilization by adenine nucleotide translocator interacting with HIV-1 viral protein rR and Bcl-2. J Exp Med (2001) 2.07
On the synthesis and destruction of A- and B-type cyclins during oogenesis and meiotic maturation in Xenopus laevis. J Cell Biol (1991) 2.06
A post-ribosomal supernatant from activated Xenopus eggs that displays post-translationally regulated oscillation of its cdc2+ mitotic kinase activity. EMBO J (1989) 2.05
Two cases of X/autosome translocation in females with incontinentia pigmenti. Hum Genet (1985) 2.05
Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency. Hum Mol Genet (2003) 2.04
Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q10 deficiency. Lancet (2000) 2.00
Special modifications of the fluorescent screening method for glucose-6-phosphate dehydrogenase deficiency. Blood (1968) 1.99
Clear correlation of genotype with disease phenotype in very-long-chain acyl-CoA dehydrogenase deficiency. Am J Hum Genet (1999) 1.99
Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease. Gastroenterology (1993) 1.97
A simple and accurate spectrophotometric assay for phosphoenolpyruvate carboxylase activity. Plant Physiol (1988) 1.97
Clinical and molecular features of the hereditary mixed polyposis syndrome. Gastroenterology (1997) 1.96
Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies. Rheumatology (Oxford) (2001) 1.96
Cip1 blocks the initiation of DNA replication in Xenopus extracts by inhibition of cyclin-dependent kinases. Curr Biol (1994) 1.95
Carbenoxolone in the treatment of duodenal ulcer. Practitioner (1967) 1.95
Observation of covalent intermediates in an enzyme mechanism at atomic resolution. Science (2001) 1.92
Antibody to human T-lymphotropic virus type 1 in West-Indian-born UK residents with spastic paraparesis. Lancet (1987) 1.92
E-cadherin expression in colorectal cancer. An immunocytochemical and in situ hybridization study. Am J Pathol (1993) 1.89
Identification of the domains in cyclin A required for binding to, and activation of, p34cdc2 and p32cdk2 protein kinase subunits. Mol Biol Cell (1992) 1.85
Guillain-Barré syndrome and Hodgkin's disease: three cases with immunological studies. Ann Neurol (1977) 1.84
Cyclin B2-null mice develop normally and are fertile whereas cyclin B1-null mice die in utero. Proc Natl Acad Sci U S A (1998) 1.82
Late-onset corticohippocampal neurodepletion attributable to catastrophic failure of oxidative phosphorylation in MILON mice. J Neurosci (2001) 1.81
Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes. Am J Hum Genet (2001) 1.81
Characterization of human homologs of the Drosophila seven in absentia (sina) gene. Genomics (1997) 1.79
Bcl-2 expression in adult and embryonic non-haematopoietic tissues. J Pathol (1993) 1.78
Loss of plectin causes epidermolysis bullosa with muscular dystrophy: cDNA cloning and genomic organization. Genes Dev (1996) 1.75
The effect of cyclic AMP and related compounds on the control of protein synthesis in reticulocyte lysates. Biochem Biophys Res Commun (1974) 1.74